ArticleJournal of clinical medicine2021

Real-World Incidence of Febrile Neutropenia among Patients Treated with Single-Agent Amrubicin: Necessity of the Primary Prophylactic Administration of Granulocyte Colony-Stimulating Factor.

Yosuke Dotsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.